By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy
Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Oral Solid Dosage Forms (OSDF) and Pharma Excipients manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Oral Solid Dosage Forms (OSDF) and Pharma Excipients market. Further, it explains the major drivers and regional dynamics of the global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
- ABITEC Corporation
- AkzoNobel
- Archer Daniels Midland (ADM)
- BASF
- DowDuPont
- Evonik
- J.M. Huber Corporation
- Cargill
- Eastman Chemical Company
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Segment by Type
- Glycerin
- Propylene Glycol
- Sorbitol
- Mannitol
- Others
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Segment by Application
- Industrial Application
- Non-industrial Application
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Oral Solid Dosage Forms (OSDF) and Pharma Excipients production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Oral Solid Dosage Forms (OSDF) and Pharma Excipients market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Oral Solid Dosage Forms (OSDF) and Pharma Excipients, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Oral Solid Dosage Forms (OSDF) and Pharma Excipients, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Oral Solid Dosage Forms (OSDF) and Pharma Excipients, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Solid Dosage Forms (OSDF) and Pharma Excipients sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Oral Solid Dosage Forms (OSDF) and Pharma Excipients sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including ABITEC Corporation, AkzoNobel, Archer Daniels Midland (ADM), BASF, DowDuPont, Evonik, J.M. Huber Corporation, Cargill and Eastman Chemical Company, etc.
Table of Contents
1 Report Overview
1.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Research Scope
1.2 Market Segment by Type
1.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Glycerin
1.2.3 Propylene Glycol
1.2.4 Sorbitol
1.2.5 Mannitol
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Industrial Application
1.3.3 Non-industrial Application
1.4 Study Objectives
1.5 Years Considered
2 Global Market Production
2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (2017-2028)
2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Region: 2017 VS 2021 VS 2028
2.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Region
2.3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Historic Production by Region (2017-2022)
2.3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Forecasted Production by Region (2023-2028)
2.3.3 North America
2.3.4 Europe
2.3.5 Japan
2.3.6 China
2.3.7 South Korea
2.3.8 India
2.4 Market Dynamics
2.4.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Industry Trends
2.4.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Drivers
2.4.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Challenges
2.4.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Restraints
3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales
3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Estimates and Forecasts 2017-2028
3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Estimates and Forecasts 2017-2028
3.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Regions by Sales
3.4.1 Global Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Regions by Sales (2017-2022)
3.4.2 Global Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Regions by Sales (2023-2028)
3.5 Global Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Regions by Revenue
3.5.1 Global Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Regions by Revenue (2017-2022)
3.5.2 Global Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Regions by Revenue (2023-2028)
3.5.3 North America
3.5.4 Europe
3.5.5 Asia-Pacific
3.5.6 Latin America
3.5.7 Middle East & Africa
4 Competition by Manufacturers
4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity by Manufacturers
4.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Manufacturers
4.2.1 Global Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers by Sales (2017-2022)
4.2.2 Global Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers Market Share by Sales (2017-2022)
4.2.3 Global Top 10 and Top 5 Companies by Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales in 2021
4.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturers
4.3.1 Global Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers by Revenue (2017-2022)
4.3.2 Global Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers Market Share by Revenue (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue in 2021
4.4 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Estimates and Forecasts by Type
5.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type
5.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Historical Sales by Type (2017-2022)
5.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Forecasted Sales by Type (2023-2028)
5.1.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2017-2028)
5.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type
5.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Historical Revenue by Type (2017-2022)
5.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Forecasted Revenue by Type (2023-2028)
5.2.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Type (2017-2028)
5.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Type
5.3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Type (2017-2022)
5.3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application
6.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Historical Sales by Application (2017-2022)
6.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Forecasted Sales by Application (2023-2028)
6.1.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2017-2028)
6.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application
6.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Historical Revenue by Application (2017-2022)
6.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Forecasted Revenue by Application (2023-2028)
6.2.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Application (2017-2028)
6.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Application
6.3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Application (2017-2022)
6.3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price Forecast by Application (2023-2028)
7 North America
7.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Breakdown by Company
7.1.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Company (2017-2022)
7.1.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Company (2017-2022)
7.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Type
7.2.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2028)
7.2.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2028)
7.3 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Application
7.3.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2028)
7.3.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2028)
7.4 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Country
7.4.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2028)
7.4.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2028)
7.4.3 U.S.
7.4.4 Canada
8 Europe
8.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Breakdown by Company
8.1.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Company (2017-2022)
8.1.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Company (2017-2022)
8.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Type
8.2.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2028)
8.2.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2028)
8.3 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Application
8.3.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2028)
8.3.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2028)
8.4 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Country
8.4.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2028)
8.4.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2028)
8.4.3 Germany
8.4.4 France
8.4.5 U.K.
8.4.6 Italy
8.4.7 Russia
9 Asia Pacific
9.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Breakdown by Company
9.1.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Company (2017-2022)
9.1.2 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Company (2017-2022)
9.2 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Type
9.2.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2028)
9.2.2 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2028)
9.3 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Application
9.3.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2028)
9.3.2 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2028)
9.4 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Region
9.4.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2017-2028)
9.4.2 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2017-2028)
9.4.3 China
9.4.4 Japan
9.4.5 South Korea
9.4.6 India
9.4.7 Australia
9.4.8 Taiwan
9.4.9 Indonesia
9.4.10 Thailand
9.4.11 Malaysia
9.4.12 Philippines
10 Latin America
10.1 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Breakdown by Company
10.1.1 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Company (2017-2022)
10.1.2 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Company (2017-2022)
10.2 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Type
10.2.1 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2028)
10.2.2 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2028)
10.3 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Application
10.3.1 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2028)
10.3.2 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2028)
10.4 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Country
10.4.1 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2028)
10.4.2 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2028)
10.4.3 Mexico
10.4.4 Brazil
10.4.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Breakdown by Company
11.1.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Company (2017-2022)
11.1.2 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Company (2017-2022)
11.2 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Type
11.2.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2028)
11.2.2 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2028)
11.3 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Application
11.3.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2028)
11.3.2 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2028)
11.4 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Country
11.4.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2028)
11.4.2 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2028)
11.4.3 Turkey
11.4.4 Saudi Arabia
11.4.5 U.A.E
12 Company Profiles
12.1 ABITEC Corporation
12.1.1 ABITEC Corporation Corporation Information
12.1.2 ABITEC Corporation Overview
12.1.3 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2017-2022)
12.1.4 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products and Services
12.1.5 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients SWOT Analysis
12.1.6 ABITEC Corporation Recent Developments
12.2 AkzoNobel
12.2.1 AkzoNobel Corporation Information
12.2.2 AkzoNobel Overview
12.2.3 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2017-2022)
12.2.4 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products and Services
12.2.5 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients SWOT Analysis
12.2.6 AkzoNobel Recent Developments
12.3 Archer Daniels Midland (ADM)
12.3.1 Archer Daniels Midland (ADM) Corporation Information
12.3.2 Archer Daniels Midland (ADM) Overview
12.3.3 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2017-2022)
12.3.4 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products and Services
12.3.5 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients SWOT Analysis
12.3.6 Archer Daniels Midland (ADM) Recent Developments
12.4 BASF
12.4.1 BASF Corporation Information
12.4.2 BASF Overview
12.4.3 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2017-2022)
12.4.4 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products and Services
12.4.5 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients SWOT Analysis
12.4.6 BASF Recent Developments
12.5 DowDuPont
12.5.1 DowDuPont Corporation Information
12.5.2 DowDuPont Overview
12.5.3 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2017-2022)
12.5.4 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products and Services
12.5.5 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients SWOT Analysis
12.5.6 DowDuPont Recent Developments
12.6 Evonik
12.6.1 Evonik Corporation Information
12.6.2 Evonik Overview
12.6.3 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2017-2022)
12.6.4 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products and Services
12.6.5 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients SWOT Analysis
12.6.6 Evonik Recent Developments
12.7 J.M. Huber Corporation
12.7.1 J.M. Huber Corporation Corporation Information
12.7.2 J.M. Huber Corporation Overview
12.7.3 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2017-2022)
12.7.4 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products and Services
12.7.5 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients SWOT Analysis
12.7.6 J.M. Huber Corporation Recent Developments
12.8 Cargill
12.8.1 Cargill Corporation Information
12.8.2 Cargill Overview
12.8.3 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2017-2022)
12.8.4 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products and Services
12.8.5 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients SWOT Analysis
12.8.6 Cargill Recent Developments
12.9 Eastman Chemical Company
12.9.1 Eastman Chemical Company Corporation Information
12.9.2 Eastman Chemical Company Overview
12.9.3 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2017-2022)
12.9.4 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products and Services
12.9.5 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients SWOT Analysis
12.9.6 Eastman Chemical Company Recent Developments
13 Value Chain and Sales Channels Analysis
13.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Value Chain Analysis
13.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Mode & Process
13.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Marketing
13.4.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Channels
13.4.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Distributors
13.5 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Customers
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Glycerin
Table 3. Major Manufacturers of Propylene Glycol
Table 4. Major Manufacturers of Sorbitol
Table 5. Major Manufacturers of Mannitol
Table 6. Major Manufacturers of Others
Table 7. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Region: 2017 VS 2021 VS 2028 (K Units)
Table 9. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Region (2017-2022) & (K Units)
Table 10. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share by Region (2017-2022)
Table 11. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Region (2023-2028) & (K Units)
Table 12. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share by Region (2023-2028)
Table 13. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Trends
Table 14. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Drivers
Table 15. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Challenges
Table 16. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Restraints
Table 17. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 18. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2017-2022) & (K Units)
Table 19. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region (2017-2022)
Table 20. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2023-2028) & (K Units)
Table 21. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region (2023-2028)
Table 22. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2017-2022) & (US$ Million)
Table 23. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Region (2017-2022)
Table 24. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2023-2028) & (US$ Million)
Table 25. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Region (2023-2028)
Table 26. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity by Manufacturers (2017-2022) & (K Units)
Table 27. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Capacity Market Share by Manufacturers (2017-2022)
Table 28. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Manufacturers (2017-2022) & (K Units)
Table 29. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share by Manufacturers (2017-2022)
Table 30. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Manufacturers (2017-2022) & (K Units)
Table 31. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Manufacturers (2017-2022)
Table 32. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 33. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Manufacturers (2017-2022)
Table 34. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Manufacturers 2017-2022 (USD/Unit)
Table 35. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Solid Dosage Forms (OSDF) and Pharma Excipients as of 2021)
Table 37. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturing Base Distribution and Headquarters
Table 38. Manufacturers Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Offered
Table 39. Date of Key Manufacturers Enter into Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market
Table 40. Mergers & Acquisitions, Expansion Plans
Table 41. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 42. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 43. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Type (2017-2022)
Table 44. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Type (2023-2028)
Table 45. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2022) & (US$ Million)
Table 46. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2023-2028) & (US$ Million)
Table 47. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Type (2017-2022)
Table 48. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Type (2023-2028)
Table 49. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Type (2017-2022) & (USD/Unit)
Table 50. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price Forecast by Type (2023-2028) & (USD/Unit)
Table 51. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 52. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 53. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Application (2017-2022)
Table 54. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Application (2023-2028)
Table 55. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2022) & (US$ Million)
Table 56. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2023-2028) & (US$ Million)
Table 57. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Application (2017-2022)
Table 58. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Application (2023-2028)
Table 59. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Application (2017-2022) & (USD/Unit)
Table 60. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price Forecast by Application (2023-2028) & (USD/Unit)
Table 61. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Company (2017-2022) & (K Units)
Table 62. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Company (2017-2022)
Table 63. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Company (2017-2022) & (US$ Million)
Table 64. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Company (2017-2022)
Table 65. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 66. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 67. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2022) & (US$ Million)
Table 68. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2023-2028) & (US$ Million)
Table 69. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 70. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 71. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2022) & (US$ Million)
Table 72. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2023-2028) & (US$ Million)
Table 73. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2022) & (K Units)
Table 74. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2023-2028) & (K Units)
Table 75. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2022) & (US$ Million)
Table 76. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2023-2028) & (US$ Million)
Table 77. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Company (2017-2022) & (K Units)
Table 78. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Company (2017-2022)
Table 79. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Company (2017-2022) & (US$ Million)
Table 80. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Company (2017-2022)
Table 81. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 82. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 83. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2022) & (US$ Million)
Table 84. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2023-2028) & (US$ Million)
Table 85. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 86. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 87. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2022) & (US$ Million)
Table 88. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2023-2028) & (US$ Million)
Table 89. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2022) & (K Units)
Table 90. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2023-2028) & (K Units)
Table 91. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2022) & (US$ Million)
Table 92. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2023-2028) & (US$ Million)
Table 93. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Company (2017-2022) & (K Units)
Table 94. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Company (2017-2022)
Table 95. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Company (2017-2022) & (US$ Million)
Table 96. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Company (2017-2022)
Table 97. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 98. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 99. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2022) & (US$ Million)
Table 100. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2023-2028) & (US$ Million)
Table 101. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 102. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 103. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2022) & (US$ Million)
Table 104. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2023-2028) & (US$ Million)
Table 105. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2017-2022) & (K Units)
Table 106. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2023-2028) & (K Units)
Table 107. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2017-2022) & (US$ Million)
Table 108. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2023-2028) & (US$ Million)
Table 109. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Company (2017-2022) & (K Units)
Table 110. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Company (2017-2022)
Table 111. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Company (2017-2022) & (US$ Million)
Table 112. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Company (2017-2022)
Table 113. Latin America Oral Soli
Write comment about above report:
Related Reports
|
Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Insights, Forecast to 2028
Oral Solid Dosage Forms (OSDF) and Pharma Excipients market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market will be able to gain the uppe... |
|
Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Growth 2022-2028
As the global economy mends, the 2021 growth of Oral Solid Dosage Forms (OSDF) and Pharma Excipients will have significant change from previous year. According to our (LP Information) latest study, the global Oral Solid Dosage Forms (OSDF) and Pharma... |
|
Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Research Report 2022
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides con... |
|
Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Research Report 2021
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides con... |
|
Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Report 2021
The global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Solid Dosage Forms (OSDF) and Pharma Excip... |
|
Global and United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Insights, Forecast to 2027
Oral Solid Dosage Forms (OSDF) and Pharma Excipients market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Oral Solid Dosage Forms (OSDF) and Pharma Excipients marke... |
|
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market - Global Outlook and Forecast 2021-2027
This report contains market size and forecasts of Oral Solid Dosage Forms (OSDF) and Pharma Excipients in global, including the following market information: Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Revenue, 2016-2021... |
|
2020-2025 Global and Regional Oral Solid Dosage Forms (OSDF) and Pharma Excipients Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report
HNY Research projects that the Oral Solid Dosage Forms (OSDF) and Pharma Excipients market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected fr... |
|
Oral Solid Dosage Forms Osdf And Pharma Excipients Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
Oral Solid Dosage Forms Osdf And Pharma Excipients Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Oral Solid Dosage Forms Osdf And Pharma Excipients industry with a focus on t... |
|
Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026
According to HJ Research's study, the global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forec... |
We are on:
Why ReportsnReports.com?
- 500,000 market research reports and growing.
- Top Fortune 500 Organizations trust us for research data.
- 24/7 support on call as well as emails.
- Your Details are safe with us.
- Free support for your research requirements.
- Report Delivery: Email
- Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays